1. Adding a second independent director 2. Filing for uplisting to OTC-QB 3. Announcement of clinical/scientific advisors 4. News flow relating to ovarian cancer trial 5. Fiscal year-end filings 6. Acquisition of new technology 7. Announcement of Asian partner
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.